The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel
Phase 2
Completed
- Conditions
- Coronary Artery DiseasePlatelet Aggregation InhibitorsPercutaneous Coronary Intervention
- Interventions
- First Posted Date
- 2018-07-26
- Last Posted Date
- 2019-09-23
- Lead Sponsor
- Jiangsu vcare pharmaceutical technology co., LTD
- Target Recruit Count
- 279
- Registration Number
- NCT03599284
- Locations
- 🇨🇳
Second Xiangya Hospital of Central South University, Changsha, Hunan, China
🇨🇳Qinghai Provincial People's Hospital, Xining, Qinghai, China
🇨🇳Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China
© Copyright 2025. All Rights Reserved by MedPath